Dr. Zelalem Makonnen, MD

Dr. Makonnen practices at University of Maryland Rehabilitation & Orthopaedic Institute in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Makonnen's NPI, 1700826120, was assigned on June 7, 2006. Dr. Makonnen holds Maryland license D0058009.

Dr. Makonnen's primary practice is University of Maryland Rehabilitation & Orthopaedic Institute, at 2200 Kernan Drive, Baltimore, MD 21207 in Baltimore County. The practice phone is (410) 448-6701.

Dr. Makonnen's primary practice is University of Maryland Rehabilitation & Orthopaedic Institute in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Makonnen is also affiliated with University of Maryland Medical Center. The medical group on file is M Medical Group. Dmand AI also links Dr. Makonnen to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makonnen practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Makonnen's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Makonnen is licensed in Maryland.

CMS data shows 1,010 Medicare services from Dr. Makonnen across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $93,230 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Makonnen in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Makonnen's median patient age at 72, with 44% women.

In 2024, Dr. Makonnen wrote 224 Medicare Part D claims for 62 patients. 88% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $82 in total drug cost. In 2023, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Makonnen for performance year 2024, reported as part of a group. Dr. Makonnen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Makonnen from 2 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $59.